Literature DB >> 17174883

RNA interference: big applause for silencing in Stockholm.

Phillip D Zamore1.   

Abstract

Eight years ago, Craig Mello, Andrew Fire, and their coworkers provided the first demonstration that double-stranded RNA (dsRNA) triggers the gene-silencing technique that we now call RNA interference (RNAi). For this landmark discovery, Mello and Fire are honored with this year's Nobel Prize in Physiology or Medicine.

Mesh:

Substances:

Year:  2006        PMID: 17174883     DOI: 10.1016/j.cell.2006.12.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  16 in total

Review 1.  Current progress in the development of RNAi-based therapeutics for HIV-1.

Authors:  J Zhou; J J Rossi
Journal:  Gene Ther       Date:  2011-09-29       Impact factor: 5.250

Review 2.  Experimental animal model and RNA interference: a promising association for bladder cancer research.

Authors:  Leonardo Oliveira Reis; Tiago Campos Pereira; Wagner José Favaro; Valéria Helena Alves Cagnon; Iscia Lopes-Cendes; Ubirajara Ferreira
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

Review 3.  Application of RNA interference in treating human diseases.

Authors:  S Abdolhamid Angaji; Sara Sadate Hedayati; Reihane Hosein Poor; Safoura Madani; Sanaz Samad Poor; Samin Panahi
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

4.  A fabricated siRNA nanoparticle for ultra-long gene silencing in vivo.

Authors:  Seung Koo Lee; Ching-Hsuan Tung
Journal:  Adv Funct Mater       Date:  2013-07-26       Impact factor: 18.808

5.  RNAi screening of the kinome with cytarabine in leukemias.

Authors:  Raoul Tibes; James M Bogenberger; Leena Chaudhuri; R Tanner Hagelstrom; Donald Chow; Megan E Buechel; Irma M Gonzales; Tim Demuth; James Slack; Ruben A Mesa; Esteban Braggio; Hongwei H Yin; Shilpi Arora; David O Azorsa
Journal:  Blood       Date:  2012-01-20       Impact factor: 22.113

Review 6.  The hammerhead ribozyme: structure, catalysis, and gene regulation.

Authors:  William G Scott; Lucas H Horan; Monika Martick
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  Effective gene silencing by multilayered siRNA-coated gold nanoparticles.

Authors:  Seung Koo Lee; Myung Shin Han; Subashini Asokan; Ching-Hsuan Tung
Journal:  Small       Date:  2010-12-30       Impact factor: 13.281

Review 8.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 9.  The promises and pitfalls of RNA-interference-based therapeutics.

Authors:  Daniela Castanotto; John J Rossi
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962

10.  siRNA against KIR3DL1 as a potential gene therapeutic agent in controlling HIV-1 infection.

Authors:  Geng-Feng Fu; Ji-Cheng Pan; Nan Lin; Hai-Yang Hu; Wei-Ming Tang; Jin-Shui Xu; Xiao-Liang Wang; Xiao-Qin Xu; Tao Qiu; Xiao-Yan Liu; Guo-Hong Chen; Tanmay Mahapatra; Xi-Ping Huan; Hai-Tao Yang
Journal:  Viral Immunol       Date:  2014-05-16       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.